Drug efflux transporters such as P-glycoprotein (P-gp) help maintain cellular homeostasis but are also major contributors to the development of multidrug resistance (MDR) phenomena. Since P-gp was associated with MDR, several compounds showing potential to inhibit this transporter have been identified. Particular attention has been given to natural products, namely those of plant origin, looking for highly effective and safe P-gp inhibitors with little to no interaction with other cellular or metabolic processes. Here we abridge several examples of plant compounds from distinct classes, polyketides, lignans, anthraquinones, coumarins, alkaloids, mono-and sesqui-terpenes, steroids and limonoids, which have shown the ability to modulate in vitro or in vivo the P-gp activity.
Efflux membrane transporters, also known as efflux pumps, are energy-dependent protein complexes responsible for removing several compounds, including endogenous molecules and xenobiotics, from cells through active transport. They contribute to the preservation of cell homeostasis by removing potentially toxic compounds from the intracellular space; however, they may also limit the penetration of compounds with potential to positively modulate cell functions. P-glycoprotein (P-gp) is one of the bestknown efflux membrane transporters. It has been discovered and characterised in various animal species, including humans. Human P-gp is encoded by two multidrug resistance genes, MDR1 and MDR3. It is composed of about 1280 amino acids (molecular mass around 170 KDa) arranged as two homologous halves (NH 2terminal and COOH-terminal), each one containing a transmembrane domain (TMD) and a nucleotide-binding domain (NBD). Each TMD is composed of six transmembrane α-helix segments and the twelve total segments together form a barrel-like structure that spans the plasma membrane [1] . TMDs are arranged in a specific configuration that creates a large hydrophobic pocket into which many substrates fit. ATP hydrolysis occurs at the NBDs [2] and the resulting energy is used by the TMDs to mediate the binding and efflux of P-gp substrates [1] . P-gp is therefore classified as belonging to the ATP-binding cassette (ABC) superfamily of efflux transporters. In humans, P-gp has ubiquitous expression in physiologically normal tissues, such as the small intestine epithelium, bile ducts, proximal tubules of the kidneys and endothelial cells of the blood-brain barrier, among others, as well as in many kinds of tumor cells. This expression and the effects of enhancers or inhibitors of P-gp are in the basis of the disruption of the effectiveness expected for a wide range of functional mediators and drug compounds that are P-gp substrates leading to kinetic interactions (drug-drug, food-drug and herb-drug interactions). For instance, the pharmacological profile of the beta-blocker talinolol, a P-gp substrate, can be altered by the concomitant administration of verapamil, a P-gp inhibitor. Verapamil can cause down-regulation of intestinal P-gp expression and activity, leading to increased absorption and oral bioavailability of talinolol [3] . Various foods and food ingredients, such as grapefruit juice, herbal substances or preparations, such as ginseng or its preparations can also modify Pgp activity [4] . P-gp activity is also one of the major factors that contributes to the so called multidrug resistance (MDR) phenomenon, which is characterized by the increment of the expression of the efflux transporter induced by drug treatment or diseases progression. This occurrence decreases the intracellular concentration of certain drugs, and consequently reduces their availability in the therapeutic targets [5] . Erythromycin, vinblastine, doxorubicin, cyclosporin A and lovastatin are classic examples of such drugs [4] . MDR phenomena imply the administration of reinforced doses of these drugs, increasing the risk of inherent adverse or toxic effects. Thus, significant efforts have been made to discover and develop P-gp inhibitors that, when administered concomitantly with such drugs, act as therapeutic adjuvants, increasing their intracellular availability and avoiding the need for harmful doses. The first known inhibitors (first-generation P-gp inhibitors) are drugs originally used for other pharmacological actions, then later recognized as useful P-gp modulators. Amongst the first-generation inhibitors are the anti-hypertensive drug verapamil and the immunosuppressant cyclosporine. These compounds are associated with other drugs in cancer chemotherapy protocols; Millward et al. improved chemotherapy protocols for lung cancer using verapamil associated with vindesine/ifosfamide [6] . First-generation inhibitors have revealed low specificity and efficacy and carry a high risk of toxicity. They are, for the most part, competitive inhibitors with low affinity to P-gp, therefore requiring high inhibitory concentrations. Moreover, many of the first-generation inhibitors possess high affinity for metabolism enzyme complexes, namely the isoform 3A4 of cytochrome P450 (CYP3A4), which is responsible for the metabolism of almost 50% of marketed drugs. This simultaneous inhibition may interfere with the biotransformation of such drugs compromising their therapeutic effects [7] . By modifying the structures and chirality of firstgeneration P-gp inhibitors, new compounds with less toxicity, higher potency and affinity to P-gp were achieved -the secondgeneration of P-gp inhibitors. This includes the analogues of firstgeneration inhibitors, as well as novel compounds discovered during research. Second-generation agents have a more favorable pharmacological profile than their first-generation counterparts, but most of them are still substrates of CYP3A4. Dexverapamil, the Risomer of verapamil and valspodar, a derivative of cyclosporin A, are examples of second-generation inhibitors. Dexverapamil does not exhibit anti-hypertensive adverse effect as strong as verapamil; on the other hand its toxicity is less severe than that of verapamil [8] . Michisch et al. [9] evidenced the safety and tolerance of the association dexverapamil / vinblastine for treatment of metastatic renal cell carcinoma. Further efforts were focused on the discovery of P-gp inhibitors with improved strength and selectivity. In silico modelling studies, quantitative structure-activity relationship (QSAR) models and non-competitive inhibition studies led to thirdgeneration inhibitors. Most of these novel compounds are currently in the development phase, but they have already shown high specificity for P-gp with little interference on other transporters of the ABC family and little interactions with other targets such CYP isoforms, particularly CYP3A4 [7, 10] . Despite the favourable in vitro behaviour of these agents, up until today no drug has been approved for clinical use in MDR tumors. Indeed, in vivo tests, including clinical trials performed with those compounds, were disappointing due to limitations in potency and specificity [7] . The search for P-gp modulators among natural products, particularly plant extracts and its constituents becomes, then, an object of attention seeking for a putative fourth generation of inhibitors [11] . The following sections abridge the achievements on the potential of plant metabolites from different chemical classes as P-gp inhibitors.
Natural products as P-gp inhibitors: "fourth-generation" inhibitors 1. Phenolic compounds
Phenolic and polyphenolic compounds are the most abundant and diverse secondary plant metabolites to which numerous biological activities have been assigned. Most phenolic and polyphenolic compounds are derivatives from the shikimic acid pathway; however, structure particularities allow their differentiation and classification in well-defined groups, among which is the large group of flavonoids. Flavonoids are the most investigated phenolic compounds for biological activities and their potential as P-gp inhibitors is attracting increasing attention from researchers. QSAR studies revealed a high affinity of flavonoid structures to P-gp. They bind to the transporter's NBD2, resulting in a competitive inhibition. As non-transportable substrates, flavonoids cannot exert effects on intracellular structures [12] . A very detailed review on the potential of flavonoids as P-gp inhibitors was recently published by Ferreira et al. [1] . For this reason, flavonoids will not be further considered herein and we recommend the reading of that paper; however, other types of phenolic compounds (polyketides, lignans, anthraquinones and coumarins) able to modulate P-gp activity are described below. a) Polyketides: Polyketides comprise a wide diversity of compounds biosynthesised through the decarboxylative condensation of malonyl-CoA and characterized by a chain with more than two carbonyl groups connected by a single intervening carbon atom. They can be classified according to peculiar features of their structure, such as the curcuminoid or stilbene classes.
Curcuminoids are phenolic compounds which typically possess a linear diarylheptanoid structure. Curcumin (1), a characteristic constituent of turmeric rhizome (Curcuma longa), is the gold standard of this class, frequently associated with antioxidant and anti-inflammatory activities. Nabekura et al. (proved that curcumin influences the in vitro intracellular concentration of P-gp substrates in human KB-C2 cancerous cells in a dose-dependent manner [13] .
It is also thought that curcumin prevents tumor initiation, promotion and progression [13] . Therefore, besides the role in carcinogenesis prevention, curcumin can be useful to enhance the susceptibility of tumors to anticancer drugs as a P-gp inhibitor [14] . Clinical trials show no overdose-associated toxic effects when doses as high as 12 g per day are administered orally [15] . Another phenolic polyketide, 6-gingerol (2), inhibits P-gp-associated efflux in KB-C2 multiresistant cells [13] . 6-Gingerol is a typical constituent of the ginger rhizome (Zingiber officinale) and is also used as a cancer preventive agent due to the stimulation of apoptosis, inhibition of DNA synthesis and angiogenesis [16] .
Stilbenes, a class of compounds derived from polyketide synthesis, are characterized by a trans-ethene double bond, whose carbon atoms are both substituted by phenyl groups. Resveratrol (3), the most representative stilbene, is a major phytoalexin that can be found in grapes (Vitis vinifera) and other plant species. Besides its potent antioxidant and pro-apoptotic activities, resveratrol inhibits P-gp. Furthermore, as evidenced by Nabekura et al., it increases the intracellular accumulation of rhodamine-123 and daunorubicin in KB-C2 cells due to the inhibition of P-gp-mediated efflux in a concentration-dependent manner; therefore, resveratrol is considered a promising lead for the design and biosynthesis of potent and low-toxicity MDR reversal agents [13] . b) Lignans: Lignans are phenolic compounds resulting from the condensation of two phenylpropanoid moieties. Several studies revealed the interaction of these phytochemicals with P-gp function.
Liang et al. reported the in vitro and in vivo P-gp inhibition by extracts obtained from Schisandra species containing lignans [schisandrol A (4), schisandrol B, schisanterin A, schisanterin B and schisandrin B)] [17] . These phenolic compounds were noted primarily for their antioxidant activity [17] . The intracellular (Caco-2, LLC-PK1 and L-MDR1 cells) concentration of two P-gp substrates, digoxin and vincristine, increased in a dose-dependent manner when extracts were added to the cell cultures. The authors also concluded that multiple dose administration of Schisandra extracts to mice has the long-term effect of diminishing P-gp expression in the brain and intestines [17] .
The MDR-reversing potential of lignans from burdock (Arctium lappa), a plant used in traditional Chinese medicine for thousands of years, was evidenced by Su et al. [18] . Six lignans isolated from the plant's seeds [arctigenin (5) , matairesinol, arctiin, (iso)lappaol A, lappaol C (6) and lappaol F] were combined with doxorubicin in order to test their potential to reverse MDR in human colon cancer (Caco-2) and human leukemia (CEM/ADR 5000) cell lines. All these lignans increased the efficacy of doxorubicin in Caco-2 cells, evidencing synergistic effects. In the CEM/ADR 5000 cells all of them, except lappaol C, demonstrated ability to inhibit P-gp by suppressing the efflux of rhodamine-123. However, lappaol C induced synergistic effects, leading authors to assume that it modulates the activity of other ABC transporters rather than P-gp [18] . Burdock lignans may interact with this efflux transporter by forming ionic and hydrogen bonds via their phenolic hydroxyl groups [18] .
Han and Anh evaluated the lignans of Magnolia officinalis, honokiol (7) and its structural analogues magnolol (8) and 4-Omethylhonokiol (9), on the activity and expression of P-gp in NCI/ADR-RES cells (derived from the human ovarian carcinoma cell line) [19] . Calcein-AM, which is converted in the intracellular space into a P-gp substrate (calcein), was used as an efflux probe [19] . Honokiol showed an increment of calcein-AM accumulation P-gp modulators of plant origin: a short review Natural Product Communications Vol. 11 (5) 2016 701 in the cells at a concentration of 50 µM, proving the inhibition of the P-gp mediated efflux. These lignans revealed also the ability to reduce significantly P-gp expression, depending on the concentration and duration of exposure, with magnolol being the most efficient. NCI/ADR-RES cells treated with these compounds, became more susceptible to daunorubicin, a P-gp substrate [19] .
Phyllanthin (10) and hypophyllanthin (11) , from Phyllanthus amarus, were evaluated using an in vitro model of Caco-2 cells [20] . Both lignans increased the intracellular concentration of calcein-AM, but the P-gp-inhibitory effect was lost when they were washed out of the cells before the addition of the substrate, suggesting that they bind to the transporter in a reversible manner. Neither phyllanthin nor hypophyllanthin exhibited effects on P-gp after long-term (7 days) exposure [19] . c) Anthraquinones: Anthraquinones are a class of phenolic compounds with a core structure composed of 9,10dioxoanthracene. They are associated with a broad spectrum of pharmacological actions, of which the best known are their laxative and anti-inflammatory activities. Choi et al. studied the links between the anti-inflammatory actions of anthraquinone compounds from rhubarb (Rheum rhabarbarum), particularly emodin (12) , and its ability to modulate P-gp expression and function [21] . The extension of P-gp inhibition was evaluated on Caco-2 cells by measuring the bidirectional transport of rhodamine-123. In a dosedependent manner, emodin caused down-regulation of the expression of inflammatory mediators (such as COX-2, iNOS and NO production), affected the efflux function of P-gp and inhibited P-gp expression via the MAPK/AP-1 pathway through COX-2 inhibition. The in vivo administration of emodin may consequently reduce the intestinal absorption of P-gp substrates [21] . Peng et al. evaluated the effect of the leaves of senna (Cassia angustifolia) on P-gp activity [22] . Folium sennae, a commonly used laxative herbal drug, contains several anthraquinone compounds, including aloeemodin (13) , rhein (14) and chrysophanol (15) [22] .
A decoction of senna leaves (folium sennae) increased the retaining of rhodamine 123 in the intracellular space of LS 180 colon carcinoma cells, indicating that it can suppress the efflux mediated by P-gp. This effect can partly explain why the combined intake of digoxin, a P-gp substrate, and senna can lead to a pharmacokinetic interaction and severe adverse effects [23] . P-gp inhibition restrains the efflux of digoxin into the intestinal lumen, leading to an increased concentration of the drug in the blood, thus aggravating its risk of toxicity. The concomitant use of senna and drugs with narrow therapeutic margins requires caution to ensure safety [22] .
d) Coumarins:
The potential of coumarins as MDR-reversing agents was reported. Structurally, coumarins are lactones of ohydroxycinnamic acids. They are ubiquitous in plant species, namely citrus fruits. Auraptene (16) (7-geranyloxycoumarin) is such an example, present in several citrus fruit species such as grapefruit (Citrus paradisi). Auraptene was proved to cause an increase in Pgp's basal ATPase activity, suggesting that it acts competitively as a substrate. The concentration of auraptene in grapefruit is sufficient to inhibit P-gp function, although the mechanisms behind that action have not yet been fully elucidated [14, 24] .
Kasaian et al. isolated and purified fifteen sesquiterpene coumarins from various species of Ferula and tested them for their inhibitory effects on P-gp efflux in MCF-7/Adr ovarian cancer cells (overexpressing P-gp and resistant to adriamycin and doxorubicin) [25] . The results showed that farnesiferol B (17), farnesiferol C, lehmferin and umbelliprenin (18) inhibited the P-gp-mediated efflux of rhodamine 123. It was also reported that the association of doxorubicin with these sesquiterpene coumarins reversed the cells' resistance to this cytotoxic drug. Farnesiferols B and C and lehmferin showed the most potent MDR reversal activity [25] .
Alkaloids
Alkaloids covers a wide range of structures containing a basic nitrogen atom. They are produced by a vast array of organisms, particularly plants, fungi and bacteria, and have a wide range of pharmacological actions.
Eid et al. studied the P-gp inhibitory potential of the alkaloids glaucine (19) , harmine (20) and sanguinarine (21), using P-gpexpressing Caco-2 and CEM/ADR 5000 leukemic cells and P-gp efflux probes rhodamine 123 and calcein-AM [26] . Compared with verapamil, a standard P-gp inhibitor, these alkaloids were shown to be potent inhibitors of P-gp. Accordingly, the physicochemical characteristics of these alkaloids, such as lipophilicity and basicity, underlie their strong P-gp-suppressant activity [26] . Bhardwaj et al. reported that piperine (22) inhibits P-gp-mediated efflux of digoxin and cyclosporine in Caco-2 cell monolayers [27] .
Han et al. studied the in vitro and in vivo effects of piperine on the function and expression of P-gp (both acute and prolonged exposure) [28] . Piperine is a major constituent of the widely used spices black pepper (Piper nigrum L.) and long pepper (P. longum L.). They used Caco-2 and P-gp-overexpressing L-MDR1 cells and monitored bidirectional digoxin transport. Depending on the concentration, piperine inhibited P-gp and completely abolished the transporter's function in both cell models at the concentration of 50 µM [28] . Furthermore, the effects of prolonged exposure of P-gp to piperine were also evaluated: 48 to 72-hour exposure to piperine at 50 µM or higher concentrations increased P-gp expression in Caco-2 cell cultures. This induction appeared to occur at the transcriptional level, since an increase in MDR1 mRNA levels in the Caco-2 cells was observed simultaneously [28] . The increase of P-gp expression following prolonged exposure to piperine was mirrored in the in vivo studies using male Wistar rats. Piperine can therefore modulate P-gp activity and expression in a time-dependent and concentration-dependent process [28] . The authors recommend caution when taking P-gp substrate drugs concomitantly with foods containing piperine [28] . Capsaicin (23) is the main alkaloid constituent of hot chilli (Capsicum annuum), widely used in Asian diets and as an analgesic agent to reduce skin irritation. It was also proved to exert inhibitory activity on P-gp in human multiresistant KB-C2 cancer cells, increasing their sensitivity to vinblastine. Capsaicin also increased the intracellular levels of daunorubicin and inhibited the efflux of rhodamine 123 in KB-C2 cell cultures [29] .
The effects of acute and chronic exposure of P-gp to capsaicin in the Caco-2 cell model were also reported [29] . Capsaicin was shown to have an acute inhibitory effect on P-gp, dependent on the concentration (at 50 µM, digoxin transport was completely nullified). On the contrary, a prolonged (48 to 72 hours) exposure of the cells to capsaicin led to the up-regulation of P-gp levels of expression and function, as well as an increase of MDR1 mRNA levels. These effects were shown to be reversible [29] and, therefore, a capsaicin-rich diet should be avoided when taking drugs that are P-gp substrates, since its effects may lead to adverse P-gpmediated food-drug interactions [29] .
Lobeline (24) , a piperidine alkaloid from species of Lobelia, namely L. inflata, were also demonstrated to inhibit P-gp mediated efflux in a competitive manner [30] . Moreover, this alkaloid increased the sensitivity of Caco-2 and CEM ADR5000 cell lines to doxorubicin 702 Natural Product Communications Vol. 11 (5) 2016 Silva et al. [30] . Lobeline can therefore be a lead phytochemical for the development of new MDR reversal compounds [30] .
Terpenic compounds
Terpenes contain a number of linked units of isoprene (C 5 H 8 ), which form chains arranged as linear, cyclic or polycyclic structures. They include a large variety of organic compounds, primarily distinguishable by the number of isoprene units involved in their formation. a) Monoterpenes and sesquiterpenes: The smallest terpenes, monoterpenes and sesquiterpenes (respectively isoprenic dimers and trimers with 10 and 15 carbon atoms) are rather volatile, characteristic of aromatic plants and typical constituents of their distillates, the essential oils. Several such compounds were proved to inhibit P-gp and down-regulate its expression: Eid et al. observed that menthol (25) and aromadendrene (26) led to a higher accumulation of rhodamine 123 and calcein-AM inside Caco-2 and CEM/ADR 5000 cell lines in a dose-dependent manner [26] . The cells were further sensitized after exposure to a combination of these terpenes with digitonin [26] . The authors assume that these compounds inhibit P-gp competitively [26, 31, 32] . Yoshida et al. demonstrated that Zanthoxylum piperitum fruits and their essential oil, mainly composed of acyclic oxygenated monoterpenes, can influence P-gp efflux [33] . Citronellal (27) and citronellol (28) , major constituents of the oil, caused down-regulation of P-gpmediated digoxin transport. However, the authors could not draw any relationship between the monoterpenes' molecular structure and their inhibitory potential [33] .
Perestelo et al. isolated sixteen sesquiterpenes with a dihydro-βagarofuran (29) skeleton from the fruits of Maytenus jelskii, and tested their ability to reverse P-gp-mediated MDR in human cells transfected with the MDR1 gene [34] . All sesquiterpenes managed to inhibit P-gp-mediated efflux, and eight of them showed a degree of efficacy equal to or higher than that of the classic P-gp inhibitor verapamil, reversing the resistance of cells to daunomycin and vinblastine [34] . Carnosic acid (33) and carnosol (34) are diterpenes (terpenes with 20 carbon atoms) that can be found, for instance, in rosemary leaves (Rosmarinus officinalis). They also interfere with P-gp function [35] , causing an increase in the intracellular concentrations of rhodamine 123 and daunorubicin in in vitro models. Carnosic acid increased the sensitivity of KB-C2 tumor cells to vinblastine, even at low concentrations. Hydrophobicity of these compounds is set to be a major factor for the inhibition of Pgp-mediated efflux [35] . b) Steroids: Steroids are cyclic triterpenoids (30 carbon atoms) whose structure has typically a cyclopentanoperhydrophenanthrene core. Plant steroids accomplish several functions, amongst which the maintenance of the integrity of plant cell membranes stands out. The most ubiquitous and important plant steroids, β-sitosterol, campesterol and stigmasterol, do not have a significant effect on Pgp [14] . However, Eid et al. observed that β-sitosterol-O-glucoside (30) led to a higher accumulation of rhodamine 123 and calcein-AM in Caco-2 and CEM/ADR 5000 cancer cell lines in a concentrationdependent manner, evidencing P-gp efflux inhibition as well as down-regulation of the expression of this transporter [26] . Guggulsterone (31), a steroid ketone obtained from the resin of the guggul tree (Commiphora mukul) has been shown to increase the intracellular concentrations of rhodamine-123 and daunorubicin in KB-C2 cells with over-expression of P-gp in a concentrationdependent manner [14] . Guggulsterone showed no effect in cells not expressing this efflux transporter, so it is thought that the increase in the concentration of both compounds is due to P-gp inhibition [14] .
Guggulsterone has also been shown to stimulate the ATPase activity of P-gp, suggesting that it acts as a P-gp substrate itself and as a competitive inhibitor in its drug-binding domain [36] .
Some steroid glycosides with therapeutic value were also investigated for P-gp inhibition. One of the most representative of these compounds is digoxin (32), a cardiotonic drug isolated from the leaves of the foxglove plant (Digitalis purpurea) and a classic substrate of P-gp used in laboratorial assays.
Another sixty-nine naturally occurring cardiotonic steroids and their derivatives were investigated for their ability to inhibit P-gp in leukemia cells [37] . The expression of P-gp was analyzed by highthroughput flow cytometry and six compounds were highlighted as being able to inhibit this efflux transporter. All of them were quite hydrophobic compounds and acted on the modulator site of P-gp; steroids with a more hydrophilic nature did not seem to interact with that site. The authors suggest that these compounds also interact with the TMDs and NBDs similarly to flavonoid compounds [37] . Some plant steroidal glycosides, as well as cyclic triterpenoids characterized by foaming capabilities, known as saponins, have also been shown to inhibit P-gp-mediated efflux [38] . Gracillin and polyphyllin D (35) , isolated from Paris polyphylla, and astragaloside II (36) , isolated from Astragalus membranaceus, are examples of steroidal saponins reported to reduce P-gp-mediated efflux [38] . It was also assumed that astragaloside II can cause down-regulation of the expression of the P-gp and MDR1 genes [38] .
Ginsenosides are triterpene glycosides typical of the ginseng plant (Panax ginseng). The root of this plant has been used in herbal medicine formulations in eastern Asia for over 2000 years [39] . Ginsenosides and their metabolites exhibit a plethora of pharmacological effects, including immunostimulation, antioxidant and anticancer activity, as well as stimulation of the central nervous system [39] . 20(S)-Protopanaxadiol (PPD) (37), a metabolite of ginsenoside Rg3, has been shown to possess significant anticancer activity and a strong P-gp-inhibitory potential in tumor cells, and also has low toxicity, making it an ideal chemosensitizer for the reversal of MDR in tumors [39] . Liu et al. designed and synthesized a series of derivatives of PPD in order to evaluate their P-gp-inhibiting potential and MDR chemosensitizing effects, using anticancer drugs such as vincristine. The PPD analogues that were revealed to be active also showed no cytotoxicity, and intracellular accumulation studies have clearly displayed that novel PPD analogues interfere with P-gp function. Therefore, PPD and its analogues can be used as a lead for the development of nontoxic P-gp-inhibiting drugs [39] . Protopanaxatriol ginsenosides can also be used as P-gpmediated MDR reversal agents because they have been shown to increase the intracellular concentration of drugs by interacting directly with P-gp at the azidopine site [38] .
c) Limonoids (tetranortriterpenes):
Limonoids are secondary metabolites analogous to limonin (38) , first identified in species of Citrus, associated with a wide spectrum of pharmacological activities including antimicrobial and anticancer.
El-Readi et al. investigated the potential of limonin and deacetylnomilin from Citrus jambhiri and C. pyriformis to inhibit P-gp and reverse doxorubicin resistance in CEM/ADR5000 and Caco-2 cells, using rhodamine 123 as a probe substrate [40] . Both P-gp modulators of plant origin: a short review Natural Product Communications Vol. 11 (5) compounds managed to reduce significantly P-gp efflux in CEM/ADR5000 cells at non-toxic concentrations and restored the cytotoxicity of doxorubicin in Caco-2 cells. Limonin also increased the susceptibility of the CEM/ADR5000 cells to doxorubicin and was revealed to be the most active compound [40] .
Conclusion:
Over the years, researchers have obtained a lot of information regarding P-gp and its function in the human body. P-gp´s role in the clearance of xenobiotics, as well as its effects on the efficacy and safety of some therapeutic regimes have been emphasised. A wide range of phytochemicals, encompassing several families, showing potential to interfere with the expression and / or activity of P-gp were also evidenced. The presence of such compounds in plant products, fruits, vegetables, medicinal herbal substances, herbal preparations and herbal medicines can thus explain the unexpected effects often experienced when they are consumed concomitantly with P-gp substrate drugs. The knowledge about the interference of these phytochemicals allows the anticipation of harmful events resulting from food-drug, plant-drug and herbal medicine-drug interactions. Additionally some of these phytochemicals (the fourth generation P-gp inhibitors) can be expected to inspire valuable leads for development of novel therapeutically valuable agents able to reverse MDR phenomena, being particularly useful in anticancer therapy. 
